65,437 trials
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Proportion of CAPTURE+ Participants Who Meet a Composite Endpoint for Diagnosis and Management of COPD — 45.9; 41.9 percent — p=0.47
Quality of Life
Primary: Chubon Lifestyle Score — 103.9; 100.9; 100.4; 102.9 score on a scale
Exocrine Pancreatic Insufficiency · Cystic Fibrosis
Primary: Safety of Adrulipase — 2 Participants
Cerebral Palsy
Primary: Change in Gross Motor Function Measure (GMFM-66) During Treatment Phase — 2.2; 3.5 units on a scale
Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Peritoneal Carcinomatosis
Primary: Overall Survival — 22.1 Months
Intubation · Laryngoscopy
Primary: The Number of Intubation Attempts With the Initial Laryngoscopy Instrument. — 4336; 3710; 70; 277 Surgical procedures — p=<0.001
Crohn Disease · Ulcerative Colitis · Inflammatory Bowel Diseases
Primary: Level of Psychological Distress — 60.8; 59.4 T-score
Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype
Primary: Neurologic Disease Progression: Number of Participants According to Muscle Weakness Assessment by Neuropathy Impairment Score (NIS) Subscale Score — 2; 2; 3 Participants
Churg-Strauss Syndrome · Eosinophilic Granulomatosis With Polyangiitis
Primary: Number of Participants With Any Adverse Events (AEs), Serious Adverse Events (SAEs) and Adverse Events of Special Interests (AESI) — 69; 26; 42 Participants
Autism Spectrum Disorder · Sleep Disturbance
Primary: Change From Baseline on MSPSQ-CSI — -2.09; -0.64; -3.31; -1.46 units on a scale — p=<0.001
Mild Cognitive Impairment · Memory Disorders · Memory Impairment
Primary: Change in the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) — -0.89; 0.55 score
Migraine Headache
Primary: Number of Headache Days at 3 Months — 18.17; 19.19; 16.47; 18.26 headache days — p=0.61
COVID19
Primary: Time to Sustained Resolution of COVID-19 Signs and Symptoms in All Subjects (With Mild or Moderate Disease at Baseline). — 113.5; 172.1; 115.1; 63.8 Time in hours…
Phantom Limb Pain · Residual Limb Pain
Primary: Change in Average RESIDUAL Limb Pain Scores Between Baseline and Day 28 of the Initial Treatment as Measured With the Numeric Rating Scale — 2.5; 0 score on a scale
Transfusion-dependent Anemia
Primary: Percentage of Overall Compliance Using Stick Pack or Tablet Counts in Iron Chelation Therapy (ICT)-naïve Participants During the Core Phase — 89.45; 91.78 percentage of…